Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Authority:

United States: Federal Government

Study ID:

PTLD (completed)

NCT ID:

NCT00063648

Start Date:

May 2002

Completion Date:

December 2007

Related Keywords:

• Liver Disease
• Lymphoproliferative Disorders
• PTLD
• CTL Therapy
• Post-transplant lymphoproliferative disorder
• Liver Diseases
• Lymphoproliferative Disorders

Name	Location
Texas Children's Hospital	Houston, Texas